Point72 Asset Management »

Context Therapeutics shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $78k 53k 1.47

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Amazon (AMZN)
Broadcom (AVGO)
Arista Networks Com Shs (ANET)
Microsoft Corporation (MSFT)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Asml Holding N V N Y Registry Shs (ASML)
Spotify Technology S A SHS (SPOT)
Sea Sponsord Ads (SE)
Biogen Idec (BIIB)
Equinix (EQIX)
Coherent Corp (COHR)

View all positions for Point72 Asset Management

Top funds holding Context Therapeutics

MPM Oncology Impact Management
Blue Owl Capital Holdings
Deep Track Capital
Nextech Invest
Avidity Partners Management
Dr. Jeffrey R. Jay, M.D.
Franklin Resources
Vanguard Group
Marshall Wace
Blackstone Group
Alyeska Investment Group
Sio Capital Management
BlackRock
Geode Capital Management
Renaissance Technologies

View all funds holding Context Therapeutics